GSK has begun the sale of some of its consumer health brands, hoping to raise around £1 billion before spinning off its consumer healthcare business, according to reports.

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

if Haleon's suite of consumer health products were performing outstandingly well, they would not have been spun out of GSK in the first place. Many of the products Haleon sells are older brands ...

The manufacturer, GSK, was going to stop manufacturing the brand-name medication in 2024 ... The FTC and others argued that ...

Mehta said HUL's focus would continue to ensure uninterrupted supplies of COVID relevant portfolio and meeting the demand arising out of evolving consumer needs ...

WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the ...

We expect the company to benefit from a consumer shift in both developed and emerging markets toward higher-end beauty brands ... and vaccine space, GSK rejoins our list of best stocks to buy ...

Mumbai: On 12 November 2024, Fireside Ventures, an early-stage venture fund focused on consumer brands, appointed Adarsh ...

GSK GSK1.94%increase; green up pointing triangle cut its full-year vaccine sales outlook after key shots for respiratory ...

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...

Haleon, the two-year-old CPG spinoff from GSK, is not only leading ... to Haleon’s pain relief brands, SeeMe also cited Kenvue’s Tylenol for prioritizing consumer wellness “through ...

Under his leadership, the North office was responsible for numerous global and Indian brands like, PepsiCo, Nestle, GSK, Hero ...